Fulton Bank N.A. lowered its holdings in shares of Danaher Co. (NYSE:DHR) by 5.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,853 shares of the conglomerate’s stock after selling 436 shares during the period. Fulton Bank N.A.’s holdings in Danaher were worth $1,767,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Brasada Capital Management LP raised its position in Danaher by 40.9% during the third quarter. Brasada Capital Management LP now owns 49,539 shares of the conglomerate’s stock worth $10,667,000 after acquiring an additional 14,384 shares during the last quarter. First City Capital Management Inc. purchased a new stake in shares of Danaher during the third quarter worth about $272,000. Cubist Systematic Strategies LLC grew its holdings in shares of Danaher by 123.7% during the third quarter. Cubist Systematic Strategies LLC now owns 12,393 shares of the conglomerate’s stock worth $2,669,000 after buying an additional 6,853 shares in the last quarter. Great West Life Assurance Co. Can grew its holdings in shares of Danaher by 1.0% during the third quarter. Great West Life Assurance Co. Can now owns 554,877 shares of the conglomerate’s stock worth $119,454,000 after buying an additional 5,582 shares in the last quarter. Finally, Sunbelt Securities Inc. grew its holdings in shares of Danaher by 8.8% during the third quarter. Sunbelt Securities Inc. now owns 5,412 shares of the conglomerate’s stock worth $1,170,000 after buying an additional 440 shares in the last quarter. Institutional investors own 78.00% of the company’s stock.
In other news, SVP Angela S. Lalor sold 6,437 shares of the business’s stock in a transaction on Friday, February 12th. The shares were sold at an average price of $244.70, for a total transaction of $1,575,133.90. Following the transaction, the senior vice president now directly owns 25,148 shares of the company’s stock, valued at $6,153,715.60. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 11.70% of the company’s stock.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, January 28th. The conglomerate reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.24. Danaher had a net margin of 18.05% and a return on equity of 12.94%. The firm had revenue of $6.76 billion for the quarter, compared to analysts’ expectations of $6.62 billion. During the same period in the previous year, the company posted $1.28 earnings per share. Danaher’s revenue was up 38.9% compared to the same quarter last year. On average, equities analysts forecast that Danaher Co. will post 6.05 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 30th. Stockholders of record on Friday, March 26th will be given a dividend of $0.21 per share. This is a boost from Danaher’s previous quarterly dividend of $0.18. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend is Thursday, March 25th. Danaher’s payout ratio is presently 19.00%.
A number of equities research analysts have recently commented on DHR shares. Credit Suisse Group lifted their price target on shares of Danaher from $260.00 to $264.00 and gave the stock an “outperform” rating in a report on Thursday, January 14th. Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating and set a $228.00 target price for the company. in a report on Tuesday, March 16th. Finally, Barclays initiated coverage on shares of Danaher in a report on Monday, March 8th. They issued an “overweight” rating and a $260.00 target price for the company. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $236.47.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: Momentum Indicators
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.